Checking effect of an ayurvedic treatment on urine and serum metabolites in hyperlipidemic patients

Investigation of metabolomics changes in serum and urine during treatment hyperlipidemia using classical ayurvedic formulation - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/08/007187

Enrollment

Registered

2016-08-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- hyperlipidemia, triglyceride 300 mg/dL and cholesterol in the range of 130- 230 mg/dL

Interventions

Intervention1: 1)Aqueous extract of Tinospora cordifolia (Willd.) Miers 2)Metformin as a standard drug: 1)Aqueous extract of Tinospora cordifolia (Willd.) Miers 100 ml/day/person for 14 days (3.0 g d

Eligibility

Inclusion criteria

Inclusion criteria: triglyceride >300 mg/dL and cholesterol in the range of 130- 230 mg/dL, must be free of anyother clinically significant diseases and addictions

Exclusion criteria

Exclusion criteria: A history of coronary heart disease or stroke, serum creatinine 1.5 mg/dl, albuminuria 40 Î¼g/min, and use of lipid-lowering drugs, aspirin, or other antihypertensive agents

Design outcomes

Primary

Measure	Time frame
Changes in blood biochemical parameters, urine and plasma chemical composition in terms of proteins and metabolitesTimepoint: 0 and 14th day	—

Secondary

Measure	Time frame
Suppression of blood high lipid content linked disordersTimepoint: 0 and 14th day	—

Countries

India

Contacts

Public ContactDr Rajesh Dabur

National Research Institute of Basic Ayurvedic Sciences (NRIBAS)

amey_593@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026